nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—ABCG2—Zafirlukast—asthma	0.0304	0.0568	CbGbCtD
Ponatinib—CYP3A5—Beclomethasone—asthma	0.0214	0.0401	CbGbCtD
Ponatinib—CYP3A5—Salmeterol—asthma	0.0214	0.0401	CbGbCtD
Ponatinib—CYP2C8—Mometasone—asthma	0.0206	0.0386	CbGbCtD
Ponatinib—CYP2C8—Salmeterol—asthma	0.0206	0.0386	CbGbCtD
Ponatinib—ABCB1—Fluticasone furoate—asthma	0.0184	0.0344	CbGbCtD
Ponatinib—CYP3A5—Fluticasone Propionate—asthma	0.0182	0.0341	CbGbCtD
Ponatinib—CYP2C8—Zafirlukast—asthma	0.0162	0.0303	CbGbCtD
Ponatinib—ABCB11—Dexamethasone—asthma	0.0162	0.0303	CbGbCtD
Ponatinib—ABCB1—Indacaterol—asthma	0.015	0.0281	CbGbCtD
Ponatinib—CYP2D6—Ciclesonide—asthma	0.0141	0.0265	CbGbCtD
Ponatinib—CYP2C8—Theophylline—asthma	0.0125	0.0234	CbGbCtD
Ponatinib—ABCG2—Hydrocortisone—asthma	0.0124	0.0231	CbGbCtD
Ponatinib—CYP2C8—Montelukast—asthma	0.0118	0.0221	CbGbCtD
Ponatinib—CYP2C8—Loratadine—asthma	0.0118	0.0221	CbGbCtD
Ponatinib—CYP2D6—Ipratropium bromide—asthma	0.0117	0.0219	CbGbCtD
Ponatinib—CYP3A4—Fluticasone furoate—asthma	0.011	0.0206	CbGbCtD
Ponatinib—CYP2D6—Zafirlukast—asthma	0.0103	0.0193	CbGbCtD
Ponatinib—CYP2D6—Formoterol—asthma	0.00996	0.0186	CbGbCtD
Ponatinib—CYP2D6—Arformoterol—asthma	0.00996	0.0186	CbGbCtD
Ponatinib—CYP3A4—Budesonide—asthma	0.00983	0.0184	CbGbCtD
Ponatinib—CYP3A4—Indacaterol—asthma	0.00899	0.0168	CbGbCtD
Ponatinib—CYP3A4—Ciclesonide—asthma	0.00899	0.0168	CbGbCtD
Ponatinib—CYP2D6—Tiotropium—asthma	0.00888	0.0166	CbGbCtD
Ponatinib—CYP3A4—Salmeterol—asthma	0.00836	0.0156	CbGbCtD
Ponatinib—CYP3A4—Flunisolide—asthma	0.00836	0.0156	CbGbCtD
Ponatinib—CYP3A4—Salbutamol—asthma	0.00836	0.0156	CbGbCtD
Ponatinib—ABCB1—Loratadine—asthma	0.00801	0.015	CbGbCtD
Ponatinib—CYP2D6—Theophylline—asthma	0.00796	0.0149	CbGbCtD
Ponatinib—ABCG2—Dexamethasone—asthma	0.00769	0.0144	CbGbCtD
Ponatinib—CYP2D6—Loratadine—asthma	0.00755	0.0141	CbGbCtD
Ponatinib—CYP3A4—Ipratropium bromide—asthma	0.00745	0.0139	CbGbCtD
Ponatinib—CYP3A4—Zileuton—asthma	0.00745	0.0139	CbGbCtD
Ponatinib—ABCB1—Methylprednisolone—asthma	0.00733	0.0137	CbGbCtD
Ponatinib—CYP3A4—Fluticasone Propionate—asthma	0.00711	0.0133	CbGbCtD
Ponatinib—CYP3A5—Hydrocortisone—asthma	0.00685	0.0128	CbGbCtD
Ponatinib—CYP2C8—Hydrocortisone—asthma	0.00659	0.0123	CbGbCtD
Ponatinib—CYP3A4—Zafirlukast—asthma	0.00656	0.0123	CbGbCtD
Ponatinib—CYP3A4—Tiotropium—asthma	0.00565	0.0106	CbGbCtD
Ponatinib—CYP3A4—Aminophylline—asthma	0.00539	0.0101	CbGbCtD
Ponatinib—RET—autonomic nervous system—asthma	0.00525	0.0599	CbGeAlD
Ponatinib—CYP3A4—Theophylline—asthma	0.00506	0.00947	CbGbCtD
Ponatinib—CYP3A4—Loratadine—asthma	0.0048	0.00898	CbGbCtD
Ponatinib—CYP3A4—Montelukast—asthma	0.0048	0.00898	CbGbCtD
Ponatinib—ABCB1—Betamethasone—asthma	0.00477	0.00892	CbGbCtD
Ponatinib—ABCB1—Prednisolone—asthma	0.0047	0.0088	CbGbCtD
Ponatinib—ABCB1—Hydrocortisone—asthma	0.00446	0.00834	CbGbCtD
Ponatinib—ABCB1—Prednisone—asthma	0.00444	0.00831	CbGbCtD
Ponatinib—CYP3A4—Methylprednisolone—asthma	0.00439	0.00822	CbGbCtD
Ponatinib—CYP3A5—Dexamethasone—asthma	0.00426	0.00797	CbGbCtD
Ponatinib—CYP2C8—Dexamethasone—asthma	0.0041	0.00766	CbGbCtD
Ponatinib—CYP3A4—Triamcinolone—asthma	0.00333	0.00623	CbGbCtD
Ponatinib—FGFR4—respiratory system—asthma	0.00287	0.0328	CbGeAlD
Ponatinib—CYP3A4—Betamethasone—asthma	0.00286	0.00534	CbGbCtD
Ponatinib—CYP3A4—Prednisolone—asthma	0.00282	0.00527	CbGbCtD
Ponatinib—ABCB1—Dexamethasone—asthma	0.00277	0.00519	CbGbCtD
Ponatinib—CYP3A4—Hydrocortisone—asthma	0.00267	0.005	CbGbCtD
Ponatinib—CYP3A4—Prednisone—asthma	0.00266	0.00498	CbGbCtD
Ponatinib—CYP2D6—Dexamethasone—asthma	0.00261	0.00489	CbGbCtD
Ponatinib—FGFR2—exocrine gland—asthma	0.00247	0.0281	CbGeAlD
Ponatinib—Imatinib—NTRK1—asthma	0.00211	0.872	CrCbGaD
Ponatinib—FGFR3—respiratory system—asthma	0.00196	0.0224	CbGeAlD
Ponatinib—FGFR4—adrenal gland—asthma	0.00174	0.0199	CbGeAlD
Ponatinib—KIT—exocrine gland—asthma	0.00171	0.0195	CbGeAlD
Ponatinib—BCR—respiratory system—asthma	0.0017	0.0194	CbGeAlD
Ponatinib—FLT3—respiratory system—asthma	0.00168	0.0192	CbGeAlD
Ponatinib—CYP3A4—Dexamethasone—asthma	0.00166	0.00311	CbGbCtD
Ponatinib—FGFR3—epithelium—asthma	0.00164	0.0187	CbGeAlD
Ponatinib—FGFR3—bronchus—asthma	0.00161	0.0184	CbGeAlD
Ponatinib—FGFR4—lung—asthma	0.00153	0.0174	CbGeAlD
Ponatinib—BCR—adrenal cortex—asthma	0.00142	0.0162	CbGeAlD
Ponatinib—BCR—bronchus—asthma	0.0014	0.0159	CbGeAlD
Ponatinib—FLT3—cardiovascular system—asthma	0.00129	0.0147	CbGeAlD
Ponatinib—FGFR2—respiratory system—asthma	0.00128	0.0146	CbGeAlD
Ponatinib—BCR—trachea—asthma	0.00125	0.0143	CbGeAlD
Ponatinib—FGFR1—bronchus—asthma	0.00124	0.0142	CbGeAlD
Ponatinib—TEK—respiratory system—asthma	0.00123	0.014	CbGeAlD
Ponatinib—FGFR3—adrenal gland—asthma	0.00119	0.0136	CbGeAlD
Ponatinib—RET—epithelium—asthma	0.00113	0.0129	CbGeAlD
Ponatinib—PDGFRA—respiratory system—asthma	0.00111	0.0127	CbGeAlD
Ponatinib—LCK—bronchus—asthma	0.00111	0.0127	CbGeAlD
Ponatinib—SRC—respiratory system—asthma	0.00109	0.0125	CbGeAlD
Ponatinib—FGFR2—epithelium—asthma	0.00107	0.0122	CbGeAlD
Ponatinib—FGFR3—lung—asthma	0.00104	0.0119	CbGeAlD
Ponatinib—FGFR2—smooth muscle tissue—asthma	0.00103	0.0118	CbGeAlD
Ponatinib—TEK—adrenal cortex—asthma	0.00103	0.0118	CbGeAlD
Ponatinib—TEK—epithelium—asthma	0.00103	0.0117	CbGeAlD
Ponatinib—BCR—adrenal gland—asthma	0.00103	0.0117	CbGeAlD
Ponatinib—FLT3—adrenal gland—asthma	0.00102	0.0116	CbGeAlD
Ponatinib—TEK—bronchus—asthma	0.00101	0.0116	CbGeAlD
Ponatinib—KDR—respiratory system—asthma	0.00101	0.0115	CbGeAlD
Ponatinib—LCK—trachea—asthma	0.000998	0.0114	CbGeAlD
Ponatinib—TEK—smooth muscle tissue—asthma	0.000991	0.0113	CbGeAlD
Ponatinib—FGFR2—cardiovascular system—asthma	0.000983	0.0112	CbGeAlD
Ponatinib—TEK—cardiovascular system—asthma	0.000942	0.0108	CbGeAlD
Ponatinib—FGFR1—adrenal gland—asthma	0.000914	0.0104	CbGeAlD
Ponatinib—SRC—epithelium—asthma	0.000914	0.0104	CbGeAlD
Ponatinib—BCR—lung—asthma	0.000901	0.0103	CbGeAlD
Ponatinib—PDGFRA—smooth muscle tissue—asthma	0.000898	0.0102	CbGeAlD
Ponatinib—FLT3—lung—asthma	0.000894	0.0102	CbGeAlD
Ponatinib—KIT—respiratory system—asthma	0.000891	0.0102	CbGeAlD
Ponatinib—SRC—smooth muscle tissue—asthma	0.00088	0.01	CbGeAlD
Ponatinib—PDGFRA—cardiovascular system—asthma	0.000854	0.00974	CbGeAlD
Ponatinib—KDR—adrenal cortex—asthma	0.000844	0.00963	CbGeAlD
Ponatinib—KDR—epithelium—asthma	0.00084	0.00959	CbGeAlD
Ponatinib—SRC—cardiovascular system—asthma	0.000837	0.00955	CbGeAlD
Ponatinib—KDR—bronchus—asthma	0.000828	0.00944	CbGeAlD
Ponatinib—PDGFRA—trachea—asthma	0.000824	0.0094	CbGeAlD
Ponatinib—RET—adrenal gland—asthma	0.000818	0.00934	CbGeAlD
Ponatinib—LCK—adrenal gland—asthma	0.000818	0.00934	CbGeAlD
Ponatinib—KDR—smooth muscle tissue—asthma	0.00081	0.00924	CbGeAlD
Ponatinib—FGFR1—lung—asthma	0.000801	0.00914	CbGeAlD
Ponatinib—FGFR2—adrenal gland—asthma	0.000777	0.00887	CbGeAlD
Ponatinib—ABL1—respiratory system—asthma	0.000776	0.00885	CbGeAlD
Ponatinib—KDR—cardiovascular system—asthma	0.00077	0.00879	CbGeAlD
Ponatinib—TEK—adrenal gland—asthma	0.000745	0.0085	CbGeAlD
Ponatinib—KIT—epithelium—asthma	0.000745	0.0085	CbGeAlD
Ponatinib—KDR—trachea—asthma	0.000743	0.00848	CbGeAlD
Ponatinib—KIT—bronchus—asthma	0.000733	0.00837	CbGeAlD
Ponatinib—KIT—smooth muscle tissue—asthma	0.000718	0.00819	CbGeAlD
Ponatinib—LCK—lung—asthma	0.000717	0.00818	CbGeAlD
Ponatinib—KIT—cardiovascular system—asthma	0.000683	0.00779	CbGeAlD
Ponatinib—FGFR2—lung—asthma	0.000681	0.00777	CbGeAlD
Ponatinib—PDGFRA—adrenal gland—asthma	0.000675	0.0077	CbGeAlD
Ponatinib—SRC—adrenal gland—asthma	0.000662	0.00756	CbGeAlD
Ponatinib—KIT—trachea—asthma	0.000659	0.00751	CbGeAlD
Ponatinib—TEK—lung—asthma	0.000653	0.00745	CbGeAlD
Ponatinib—ABL1—adrenal cortex—asthma	0.000651	0.00743	CbGeAlD
Ponatinib—ABL1—bronchus—asthma	0.000638	0.00728	CbGeAlD
Ponatinib—ABL1—smooth muscle tissue—asthma	0.000625	0.00713	CbGeAlD
Ponatinib—KDR—adrenal gland—asthma	0.000609	0.00695	CbGeAlD
Ponatinib—ABL1—cardiovascular system—asthma	0.000594	0.00678	CbGeAlD
Ponatinib—PDGFRA—lung—asthma	0.000592	0.00675	CbGeAlD
Ponatinib—SRC—lung—asthma	0.00058	0.00662	CbGeAlD
Ponatinib—ABL1—trachea—asthma	0.000573	0.00654	CbGeAlD
Ponatinib—KIT—adrenal gland—asthma	0.00054	0.00616	CbGeAlD
Ponatinib—KDR—lung—asthma	0.000534	0.00609	CbGeAlD
Ponatinib—KIT—lung—asthma	0.000473	0.0054	CbGeAlD
Ponatinib—ABL1—adrenal gland—asthma	0.00047	0.00536	CbGeAlD
Ponatinib—CYP3A5—respiratory system—asthma	0.000454	0.00518	CbGeAlD
Ponatinib—ABL1—lung—asthma	0.000412	0.0047	CbGeAlD
Ponatinib—ABCG2—adrenal cortex—asthma	0.000411	0.00468	CbGeAlD
Ponatinib—Imatinib—ALB—asthma	0.000309	0.128	CrCbGaD
Ponatinib—ABCG2—adrenal gland—asthma	0.000296	0.00338	CbGeAlD
Ponatinib—ABCG2—lung—asthma	0.00026	0.00296	CbGeAlD
Ponatinib—ABCB1—respiratory system—asthma	0.000241	0.00275	CbGeAlD
Ponatinib—CYP3A5—lung—asthma	0.000241	0.00275	CbGeAlD
Ponatinib—ABCB1—adrenal cortex—asthma	0.000202	0.00231	CbGeAlD
Ponatinib—ABCB1—epithelium—asthma	0.000202	0.0023	CbGeAlD
Ponatinib—ABCB1—cardiovascular system—asthma	0.000185	0.00211	CbGeAlD
Ponatinib—ABCB1—trachea—asthma	0.000178	0.00203	CbGeAlD
Ponatinib—ABCB1—adrenal gland—asthma	0.000146	0.00167	CbGeAlD
Ponatinib—ABCB1—lung—asthma	0.000128	0.00146	CbGeAlD
Ponatinib—Mental disorder—Hydrocortisone—asthma	6.15e-05	0.000306	CcSEcCtD
Ponatinib—Cardiac disorder—Methylprednisolone—asthma	6.13e-05	0.000305	CcSEcCtD
Ponatinib—Malnutrition—Hydrocortisone—asthma	6.12e-05	0.000304	CcSEcCtD
Ponatinib—Erythema—Hydrocortisone—asthma	6.12e-05	0.000304	CcSEcCtD
Ponatinib—Dizziness—Montelukast—asthma	6.11e-05	0.000304	CcSEcCtD
Ponatinib—Neutropenia—Prednisone—asthma	6.11e-05	0.000304	CcSEcCtD
Ponatinib—Pruritus—Budesonide—asthma	6.11e-05	0.000304	CcSEcCtD
Ponatinib—Diarrhoea—Salbutamol—asthma	6.1e-05	0.000303	CcSEcCtD
Ponatinib—Haemoglobin—Betamethasone—asthma	6.03e-05	0.0003	CcSEcCtD
Ponatinib—Haemoglobin—Dexamethasone—asthma	6.03e-05	0.0003	CcSEcCtD
Ponatinib—Erectile dysfunction—Prednisone—asthma	6.01e-05	0.000299	CcSEcCtD
Ponatinib—Haemorrhage—Betamethasone—asthma	6e-05	0.000299	CcSEcCtD
Ponatinib—Haemorrhage—Dexamethasone—asthma	6e-05	0.000299	CcSEcCtD
Ponatinib—Vomiting—Arformoterol—asthma	6e-05	0.000299	CcSEcCtD
Ponatinib—Vomiting—Formoterol—asthma	6e-05	0.000299	CcSEcCtD
Ponatinib—Angiopathy—Methylprednisolone—asthma	5.99e-05	0.000298	CcSEcCtD
Ponatinib—Nausea—Mometasone—asthma	5.97e-05	0.000297	CcSEcCtD
Ponatinib—Rash—Formoterol—asthma	5.95e-05	0.000296	CcSEcCtD
Ponatinib—Rash—Arformoterol—asthma	5.95e-05	0.000296	CcSEcCtD
Ponatinib—Mediastinal disorder—Methylprednisolone—asthma	5.95e-05	0.000296	CcSEcCtD
Ponatinib—Dermatitis—Arformoterol—asthma	5.94e-05	0.000296	CcSEcCtD
Ponatinib—Dermatitis—Formoterol—asthma	5.94e-05	0.000296	CcSEcCtD
Ponatinib—Headache—Arformoterol—asthma	5.91e-05	0.000294	CcSEcCtD
Ponatinib—Headache—Formoterol—asthma	5.91e-05	0.000294	CcSEcCtD
Ponatinib—Arrhythmia—Triamcinolone—asthma	5.91e-05	0.000294	CcSEcCtD
Ponatinib—Weight decreased—Prednisone—asthma	5.91e-05	0.000294	CcSEcCtD
Ponatinib—Diarrhoea—Budesonide—asthma	5.9e-05	0.000294	CcSEcCtD
Ponatinib—Vision blurred—Prednisolone—asthma	5.9e-05	0.000294	CcSEcCtD
Ponatinib—Arrhythmia—Methylprednisolone—asthma	5.9e-05	0.000294	CcSEcCtD
Ponatinib—Dizziness—Salbutamol—asthma	5.89e-05	0.000293	CcSEcCtD
Ponatinib—Hyperglycaemia—Prednisone—asthma	5.89e-05	0.000293	CcSEcCtD
Ponatinib—Vomiting—Montelukast—asthma	5.88e-05	0.000293	CcSEcCtD
Ponatinib—Rash—Montelukast—asthma	5.83e-05	0.00029	CcSEcCtD
Ponatinib—Dermatitis—Montelukast—asthma	5.82e-05	0.00029	CcSEcCtD
Ponatinib—Headache—Montelukast—asthma	5.79e-05	0.000288	CcSEcCtD
Ponatinib—Visual impairment—Dexamethasone—asthma	5.78e-05	0.000288	CcSEcCtD
Ponatinib—Visual impairment—Betamethasone—asthma	5.78e-05	0.000288	CcSEcCtD
Ponatinib—Mental disorder—Methylprednisolone—asthma	5.78e-05	0.000288	CcSEcCtD
Ponatinib—Erythema—Triamcinolone—asthma	5.76e-05	0.000287	CcSEcCtD
Ponatinib—Erythema—Methylprednisolone—asthma	5.75e-05	0.000286	CcSEcCtD
Ponatinib—Malnutrition—Methylprednisolone—asthma	5.75e-05	0.000286	CcSEcCtD
Ponatinib—Acute coronary syndrome—Prednisone—asthma	5.74e-05	0.000286	CcSEcCtD
Ponatinib—Myocardial infarction—Prednisone—asthma	5.71e-05	0.000284	CcSEcCtD
Ponatinib—Neuropathy peripheral—Prednisone—asthma	5.71e-05	0.000284	CcSEcCtD
Ponatinib—Dizziness—Budesonide—asthma	5.71e-05	0.000284	CcSEcCtD
Ponatinib—Vomiting—Salbutamol—asthma	5.66e-05	0.000282	CcSEcCtD
Ponatinib—Rash—Salbutamol—asthma	5.62e-05	0.00028	CcSEcCtD
Ponatinib—Dermatitis—Salbutamol—asthma	5.61e-05	0.000279	CcSEcCtD
Ponatinib—Eye disorder—Dexamethasone—asthma	5.61e-05	0.000279	CcSEcCtD
Ponatinib—Eye disorder—Betamethasone—asthma	5.61e-05	0.000279	CcSEcCtD
Ponatinib—Nausea—Arformoterol—asthma	5.6e-05	0.000279	CcSEcCtD
Ponatinib—Nausea—Formoterol—asthma	5.6e-05	0.000279	CcSEcCtD
Ponatinib—Headache—Salbutamol—asthma	5.58e-05	0.000278	CcSEcCtD
Ponatinib—Back pain—Triamcinolone—asthma	5.57e-05	0.000277	CcSEcCtD
Ponatinib—Nausea—Montelukast—asthma	5.49e-05	0.000273	CcSEcCtD
Ponatinib—Vomiting—Budesonide—asthma	5.49e-05	0.000273	CcSEcCtD
Ponatinib—Angiopathy—Betamethasone—asthma	5.45e-05	0.000271	CcSEcCtD
Ponatinib—Angiopathy—Dexamethasone—asthma	5.45e-05	0.000271	CcSEcCtD
Ponatinib—Rash—Budesonide—asthma	5.44e-05	0.000271	CcSEcCtD
Ponatinib—Dermatitis—Budesonide—asthma	5.44e-05	0.000271	CcSEcCtD
Ponatinib—Headache—Budesonide—asthma	5.41e-05	0.000269	CcSEcCtD
Ponatinib—Hypertension—Prednisolone—asthma	5.41e-05	0.000269	CcSEcCtD
Ponatinib—Arrhythmia—Dexamethasone—asthma	5.36e-05	0.000267	CcSEcCtD
Ponatinib—Arrhythmia—Betamethasone—asthma	5.36e-05	0.000267	CcSEcCtD
Ponatinib—Alopecia—Dexamethasone—asthma	5.3e-05	0.000264	CcSEcCtD
Ponatinib—Alopecia—Betamethasone—asthma	5.3e-05	0.000264	CcSEcCtD
Ponatinib—Nausea—Salbutamol—asthma	5.29e-05	0.000263	CcSEcCtD
Ponatinib—Hypertension—Hydrocortisone—asthma	5.28e-05	0.000263	CcSEcCtD
Ponatinib—Haemoglobin—Prednisone—asthma	5.25e-05	0.000262	CcSEcCtD
Ponatinib—Haemorrhage—Prednisone—asthma	5.23e-05	0.00026	CcSEcCtD
Ponatinib—Erythema—Dexamethasone—asthma	5.22e-05	0.00026	CcSEcCtD
Ponatinib—Erythema—Betamethasone—asthma	5.22e-05	0.00026	CcSEcCtD
Ponatinib—Myalgia—Hydrocortisone—asthma	5.21e-05	0.000259	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	5.17e-05	0.000257	CcSEcCtD
Ponatinib—Connective tissue disorder—Prednisone—asthma	5.14e-05	0.000256	CcSEcCtD
Ponatinib—Nausea—Budesonide—asthma	5.13e-05	0.000255	CcSEcCtD
Ponatinib—Oedema—Prednisolone—asthma	5.11e-05	0.000254	CcSEcCtD
Ponatinib—Cough—Triamcinolone—asthma	5.02e-05	0.00025	CcSEcCtD
Ponatinib—Oedema—Hydrocortisone—asthma	4.99e-05	0.000248	CcSEcCtD
Ponatinib—Hypertension—Triamcinolone—asthma	4.97e-05	0.000247	CcSEcCtD
Ponatinib—Hypertension—Methylprednisolone—asthma	4.96e-05	0.000247	CcSEcCtD
Ponatinib—Infection—Hydrocortisone—asthma	4.96e-05	0.000247	CcSEcCtD
Ponatinib—Hyperhidrosis—Prednisolone—asthma	4.94e-05	0.000246	CcSEcCtD
Ponatinib—Myalgia—Triamcinolone—asthma	4.9e-05	0.000244	CcSEcCtD
Ponatinib—Nervous system disorder—Hydrocortisone—asthma	4.89e-05	0.000244	CcSEcCtD
Ponatinib—Myalgia—Methylprednisolone—asthma	4.89e-05	0.000244	CcSEcCtD
Ponatinib—Arthralgia—Methylprednisolone—asthma	4.89e-05	0.000244	CcSEcCtD
Ponatinib—Eye disorder—Prednisone—asthma	4.88e-05	0.000243	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	4.86e-05	0.000242	CcSEcCtD
Ponatinib—Flushing—Prednisone—asthma	4.85e-05	0.000241	CcSEcCtD
Ponatinib—Skin disorder—Hydrocortisone—asthma	4.85e-05	0.000241	CcSEcCtD
Ponatinib—Hyperhidrosis—Hydrocortisone—asthma	4.82e-05	0.00024	CcSEcCtD
Ponatinib—Dry mouth—Triamcinolone—asthma	4.79e-05	0.000239	CcSEcCtD
Ponatinib—Angiopathy—Prednisone—asthma	4.74e-05	0.000236	CcSEcCtD
Ponatinib—Oedema—Triamcinolone—asthma	4.7e-05	0.000234	CcSEcCtD
Ponatinib—Arrhythmia—Prednisone—asthma	4.67e-05	0.000232	CcSEcCtD
Ponatinib—Infection—Triamcinolone—asthma	4.67e-05	0.000232	CcSEcCtD
Ponatinib—Infection—Methylprednisolone—asthma	4.66e-05	0.000232	CcSEcCtD
Ponatinib—Insomnia—Prednisolone—asthma	4.62e-05	0.00023	CcSEcCtD
Ponatinib—Alopecia—Prednisone—asthma	4.62e-05	0.00023	CcSEcCtD
Ponatinib—Nervous system disorder—Methylprednisolone—asthma	4.6e-05	0.000229	CcSEcCtD
Ponatinib—Paraesthesia—Prednisolone—asthma	4.59e-05	0.000228	CcSEcCtD
Ponatinib—Mental disorder—Prednisone—asthma	4.58e-05	0.000228	CcSEcCtD
Ponatinib—Skin disorder—Methylprednisolone—asthma	4.55e-05	0.000227	CcSEcCtD
Ponatinib—Erythema—Prednisone—asthma	4.55e-05	0.000227	CcSEcCtD
Ponatinib—Malnutrition—Prednisone—asthma	4.55e-05	0.000227	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Hydrocortisone—asthma	4.55e-05	0.000226	CcSEcCtD
Ponatinib—Hyperhidrosis—Triamcinolone—asthma	4.54e-05	0.000226	CcSEcCtD
Ponatinib—Hyperhidrosis—Methylprednisolone—asthma	4.53e-05	0.000226	CcSEcCtD
Ponatinib—Insomnia—Hydrocortisone—asthma	4.51e-05	0.000225	CcSEcCtD
Ponatinib—Hypertension—Betamethasone—asthma	4.51e-05	0.000225	CcSEcCtD
Ponatinib—Hypertension—Dexamethasone—asthma	4.51e-05	0.000225	CcSEcCtD
Ponatinib—Paraesthesia—Hydrocortisone—asthma	4.48e-05	0.000223	CcSEcCtD
Ponatinib—Myalgia—Dexamethasone—asthma	4.45e-05	0.000221	CcSEcCtD
Ponatinib—Myalgia—Betamethasone—asthma	4.45e-05	0.000221	CcSEcCtD
Ponatinib—Dyspepsia—Hydrocortisone—asthma	4.39e-05	0.000219	CcSEcCtD
Ponatinib—Pain—Prednisolone—asthma	4.37e-05	0.000218	CcSEcCtD
Ponatinib—Decreased appetite—Hydrocortisone—asthma	4.34e-05	0.000216	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Hydrocortisone—asthma	4.31e-05	0.000215	CcSEcCtD
Ponatinib—Fatigue—Hydrocortisone—asthma	4.3e-05	0.000214	CcSEcCtD
Ponatinib—Vision blurred—Prednisone—asthma	4.29e-05	0.000213	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Triamcinolone—asthma	4.28e-05	0.000213	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Methylprednisolone—asthma	4.27e-05	0.000213	CcSEcCtD
Ponatinib—Pain—Hydrocortisone—asthma	4.27e-05	0.000212	CcSEcCtD
Ponatinib—Oedema—Dexamethasone—asthma	4.26e-05	0.000212	CcSEcCtD
Ponatinib—Oedema—Betamethasone—asthma	4.26e-05	0.000212	CcSEcCtD
Ponatinib—Insomnia—Triamcinolone—asthma	4.25e-05	0.000212	CcSEcCtD
Ponatinib—Insomnia—Methylprednisolone—asthma	4.24e-05	0.000211	CcSEcCtD
Ponatinib—Infection—Betamethasone—asthma	4.24e-05	0.000211	CcSEcCtD
Ponatinib—Infection—Dexamethasone—asthma	4.24e-05	0.000211	CcSEcCtD
Ponatinib—Paraesthesia—Triamcinolone—asthma	4.22e-05	0.00021	CcSEcCtD
Ponatinib—Paraesthesia—Methylprednisolone—asthma	4.21e-05	0.00021	CcSEcCtD
Ponatinib—Anaemia—Prednisone—asthma	4.21e-05	0.000209	CcSEcCtD
Ponatinib—Dyspnoea—Triamcinolone—asthma	4.19e-05	0.000209	CcSEcCtD
Ponatinib—Nervous system disorder—Betamethasone—asthma	4.18e-05	0.000208	CcSEcCtD
Ponatinib—Nervous system disorder—Dexamethasone—asthma	4.18e-05	0.000208	CcSEcCtD
Ponatinib—Thrombocytopenia—Dexamethasone—asthma	4.17e-05	0.000208	CcSEcCtD
Ponatinib—Thrombocytopenia—Betamethasone—asthma	4.17e-05	0.000208	CcSEcCtD
Ponatinib—Dyspepsia—Triamcinolone—asthma	4.14e-05	0.000206	CcSEcCtD
Ponatinib—Dyspepsia—Methylprednisolone—asthma	4.13e-05	0.000205	CcSEcCtD
Ponatinib—Hyperhidrosis—Dexamethasone—asthma	4.12e-05	0.000205	CcSEcCtD
Ponatinib—Hyperhidrosis—Betamethasone—asthma	4.12e-05	0.000205	CcSEcCtD
Ponatinib—Gastrointestinal pain—Hydrocortisone—asthma	4.08e-05	0.000203	CcSEcCtD
Ponatinib—Fatigue—Triamcinolone—asthma	4.05e-05	0.000202	CcSEcCtD
Ponatinib—Fatigue—Methylprednisolone—asthma	4.04e-05	0.000201	CcSEcCtD
Ponatinib—Pain—Triamcinolone—asthma	4.02e-05	0.0002	CcSEcCtD
Ponatinib—Body temperature increased—Hydrocortisone—asthma	3.95e-05	0.000196	CcSEcCtD
Ponatinib—Abdominal pain—Hydrocortisone—asthma	3.95e-05	0.000196	CcSEcCtD
Ponatinib—Hypertension—Prednisone—asthma	3.93e-05	0.000196	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Betamethasone—asthma	3.88e-05	0.000193	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Dexamethasone—asthma	3.88e-05	0.000193	CcSEcCtD
Ponatinib—Arthralgia—Prednisone—asthma	3.87e-05	0.000193	CcSEcCtD
Ponatinib—Myalgia—Prednisone—asthma	3.87e-05	0.000193	CcSEcCtD
Ponatinib—Insomnia—Dexamethasone—asthma	3.86e-05	0.000192	CcSEcCtD
Ponatinib—Insomnia—Betamethasone—asthma	3.86e-05	0.000192	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	3.85e-05	0.000192	CcSEcCtD
Ponatinib—Gastrointestinal pain—Methylprednisolone—asthma	3.83e-05	0.000191	CcSEcCtD
Ponatinib—Paraesthesia—Dexamethasone—asthma	3.83e-05	0.000191	CcSEcCtD
Ponatinib—Paraesthesia—Betamethasone—asthma	3.83e-05	0.000191	CcSEcCtD
Ponatinib—Dyspepsia—Betamethasone—asthma	3.75e-05	0.000187	CcSEcCtD
Ponatinib—Dyspepsia—Dexamethasone—asthma	3.75e-05	0.000187	CcSEcCtD
Ponatinib—Body temperature increased—Triamcinolone—asthma	3.71e-05	0.000185	CcSEcCtD
Ponatinib—Oedema—Prednisone—asthma	3.71e-05	0.000185	CcSEcCtD
Ponatinib—Abdominal pain—Methylprednisolone—asthma	3.71e-05	0.000185	CcSEcCtD
Ponatinib—Decreased appetite—Betamethasone—asthma	3.71e-05	0.000185	CcSEcCtD
Ponatinib—Decreased appetite—Dexamethasone—asthma	3.71e-05	0.000185	CcSEcCtD
Ponatinib—Infection—Prednisone—asthma	3.69e-05	0.000184	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Dexamethasone—asthma	3.68e-05	0.000183	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Betamethasone—asthma	3.68e-05	0.000183	CcSEcCtD
Ponatinib—Fatigue—Dexamethasone—asthma	3.68e-05	0.000183	CcSEcCtD
Ponatinib—Fatigue—Betamethasone—asthma	3.68e-05	0.000183	CcSEcCtD
Ponatinib—Pain—Betamethasone—asthma	3.65e-05	0.000182	CcSEcCtD
Ponatinib—Pain—Dexamethasone—asthma	3.65e-05	0.000182	CcSEcCtD
Ponatinib—Nervous system disorder—Prednisone—asthma	3.64e-05	0.000181	CcSEcCtD
Ponatinib—Skin disorder—Prednisone—asthma	3.61e-05	0.00018	CcSEcCtD
Ponatinib—Hyperhidrosis—Prednisone—asthma	3.59e-05	0.000179	CcSEcCtD
Ponatinib—Asthenia—Hydrocortisone—asthma	3.58e-05	0.000178	CcSEcCtD
Ponatinib—Pruritus—Hydrocortisone—asthma	3.53e-05	0.000176	CcSEcCtD
Ponatinib—Gastrointestinal pain—Dexamethasone—asthma	3.49e-05	0.000174	CcSEcCtD
Ponatinib—Gastrointestinal pain—Betamethasone—asthma	3.49e-05	0.000174	CcSEcCtD
Ponatinib—Diarrhoea—Hydrocortisone—asthma	3.41e-05	0.00017	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Prednisone—asthma	3.38e-05	0.000168	CcSEcCtD
Ponatinib—Dizziness—Prednisolone—asthma	3.38e-05	0.000168	CcSEcCtD
Ponatinib—Asthenia—Triamcinolone—asthma	3.37e-05	0.000168	CcSEcCtD
Ponatinib—Abdominal pain—Dexamethasone—asthma	3.37e-05	0.000168	CcSEcCtD
Ponatinib—Body temperature increased—Dexamethasone—asthma	3.37e-05	0.000168	CcSEcCtD
Ponatinib—Abdominal pain—Betamethasone—asthma	3.37e-05	0.000168	CcSEcCtD
Ponatinib—Body temperature increased—Betamethasone—asthma	3.37e-05	0.000168	CcSEcCtD
Ponatinib—Asthenia—Methylprednisolone—asthma	3.36e-05	0.000167	CcSEcCtD
Ponatinib—Insomnia—Prednisone—asthma	3.36e-05	0.000167	CcSEcCtD
Ponatinib—Paraesthesia—Prednisone—asthma	3.33e-05	0.000166	CcSEcCtD
Ponatinib—Pruritus—Triamcinolone—asthma	3.32e-05	0.000166	CcSEcCtD
Ponatinib—Pruritus—Methylprednisolone—asthma	3.32e-05	0.000165	CcSEcCtD
Ponatinib—Dizziness—Hydrocortisone—asthma	3.3e-05	0.000164	CcSEcCtD
Ponatinib—Dyspepsia—Prednisone—asthma	3.27e-05	0.000163	CcSEcCtD
Ponatinib—Decreased appetite—Prednisone—asthma	3.23e-05	0.000161	CcSEcCtD
Ponatinib—Rash—Prednisolone—asthma	3.22e-05	0.00016	CcSEcCtD
Ponatinib—Dermatitis—Prednisolone—asthma	3.22e-05	0.00016	CcSEcCtD
Ponatinib—Diarrhoea—Methylprednisolone—asthma	3.21e-05	0.00016	CcSEcCtD
Ponatinib—Fatigue—Prednisone—asthma	3.2e-05	0.000159	CcSEcCtD
Ponatinib—Headache—Prednisolone—asthma	3.2e-05	0.000159	CcSEcCtD
Ponatinib—Constipation—Prednisone—asthma	3.18e-05	0.000158	CcSEcCtD
Ponatinib—Vomiting—Hydrocortisone—asthma	3.17e-05	0.000158	CcSEcCtD
Ponatinib—Rash—Hydrocortisone—asthma	3.15e-05	0.000157	CcSEcCtD
Ponatinib—Dermatitis—Hydrocortisone—asthma	3.14e-05	0.000157	CcSEcCtD
Ponatinib—Headache—Hydrocortisone—asthma	3.13e-05	0.000156	CcSEcCtD
Ponatinib—Dizziness—Triamcinolone—asthma	3.11e-05	0.000155	CcSEcCtD
Ponatinib—Dizziness—Methylprednisolone—asthma	3.1e-05	0.000154	CcSEcCtD
Ponatinib—Asthenia—Dexamethasone—asthma	3.06e-05	0.000152	CcSEcCtD
Ponatinib—Asthenia—Betamethasone—asthma	3.06e-05	0.000152	CcSEcCtD
Ponatinib—Gastrointestinal pain—Prednisone—asthma	3.04e-05	0.000151	CcSEcCtD
Ponatinib—Nausea—Prednisolone—asthma	3.04e-05	0.000151	CcSEcCtD
Ponatinib—Pruritus—Dexamethasone—asthma	3.02e-05	0.00015	CcSEcCtD
Ponatinib—Pruritus—Betamethasone—asthma	3.02e-05	0.00015	CcSEcCtD
Ponatinib—Vomiting—Triamcinolone—asthma	2.99e-05	0.000149	CcSEcCtD
Ponatinib—Vomiting—Methylprednisolone—asthma	2.98e-05	0.000148	CcSEcCtD
Ponatinib—Nausea—Hydrocortisone—asthma	2.96e-05	0.000148	CcSEcCtD
Ponatinib—Rash—Triamcinolone—asthma	2.96e-05	0.000148	CcSEcCtD
Ponatinib—Dermatitis—Triamcinolone—asthma	2.96e-05	0.000147	CcSEcCtD
Ponatinib—Rash—Methylprednisolone—asthma	2.96e-05	0.000147	CcSEcCtD
Ponatinib—Dermatitis—Methylprednisolone—asthma	2.95e-05	0.000147	CcSEcCtD
Ponatinib—Headache—Triamcinolone—asthma	2.94e-05	0.000147	CcSEcCtD
Ponatinib—Headache—Methylprednisolone—asthma	2.94e-05	0.000146	CcSEcCtD
Ponatinib—Abdominal pain—Prednisone—asthma	2.94e-05	0.000146	CcSEcCtD
Ponatinib—Body temperature increased—Prednisone—asthma	2.94e-05	0.000146	CcSEcCtD
Ponatinib—Diarrhoea—Dexamethasone—asthma	2.92e-05	0.000145	CcSEcCtD
Ponatinib—Diarrhoea—Betamethasone—asthma	2.92e-05	0.000145	CcSEcCtD
Ponatinib—Dizziness—Betamethasone—asthma	2.82e-05	0.00014	CcSEcCtD
Ponatinib—Dizziness—Dexamethasone—asthma	2.82e-05	0.00014	CcSEcCtD
Ponatinib—Nausea—Triamcinolone—asthma	2.79e-05	0.000139	CcSEcCtD
Ponatinib—Nausea—Methylprednisolone—asthma	2.79e-05	0.000139	CcSEcCtD
Ponatinib—Vomiting—Dexamethasone—asthma	2.71e-05	0.000135	CcSEcCtD
Ponatinib—Vomiting—Betamethasone—asthma	2.71e-05	0.000135	CcSEcCtD
Ponatinib—Rash—Dexamethasone—asthma	2.69e-05	0.000134	CcSEcCtD
Ponatinib—Rash—Betamethasone—asthma	2.69e-05	0.000134	CcSEcCtD
Ponatinib—Dermatitis—Dexamethasone—asthma	2.69e-05	0.000134	CcSEcCtD
Ponatinib—Dermatitis—Betamethasone—asthma	2.69e-05	0.000134	CcSEcCtD
Ponatinib—Headache—Dexamethasone—asthma	2.67e-05	0.000133	CcSEcCtD
Ponatinib—Headache—Betamethasone—asthma	2.67e-05	0.000133	CcSEcCtD
Ponatinib—Asthenia—Prednisone—asthma	2.66e-05	0.000133	CcSEcCtD
Ponatinib—Pruritus—Prednisone—asthma	2.63e-05	0.000131	CcSEcCtD
Ponatinib—Diarrhoea—Prednisone—asthma	2.54e-05	0.000126	CcSEcCtD
Ponatinib—Nausea—Betamethasone—asthma	2.53e-05	0.000126	CcSEcCtD
Ponatinib—Nausea—Dexamethasone—asthma	2.53e-05	0.000126	CcSEcCtD
Ponatinib—Dizziness—Prednisone—asthma	2.46e-05	0.000122	CcSEcCtD
Ponatinib—Vomiting—Prednisone—asthma	2.36e-05	0.000118	CcSEcCtD
Ponatinib—Rash—Prednisone—asthma	2.34e-05	0.000117	CcSEcCtD
Ponatinib—Dermatitis—Prednisone—asthma	2.34e-05	0.000116	CcSEcCtD
Ponatinib—Headache—Prednisone—asthma	2.33e-05	0.000116	CcSEcCtD
Ponatinib—Nausea—Prednisone—asthma	2.21e-05	0.00011	CcSEcCtD
Ponatinib—SRC—Signaling Pathways—PLA2G4A—asthma	3.21e-06	1.84e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—C3—asthma	3.21e-06	1.84e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TGFB1—asthma	3.2e-06	1.83e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—NOS3—asthma	3.19e-06	1.83e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—CAT—asthma	3.19e-06	1.83e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—CD4—asthma	3.19e-06	1.83e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CSF2—asthma	3.18e-06	1.82e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—IL6R—asthma	3.16e-06	1.81e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—STAT3—asthma	3.16e-06	1.81e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—STAT3—asthma	3.15e-06	1.81e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—TGFB1—asthma	3.14e-06	1.8e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—EGFR—asthma	3.14e-06	1.8e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—RHOA—asthma	3.13e-06	1.8e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—POMC—asthma	3.13e-06	1.79e-05	CbGpPWpGaD
Ponatinib—ABCB1—Transmembrane transport of small molecules—ALB—asthma	3.13e-06	1.79e-05	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—PTEN—asthma	3.13e-06	1.79e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—RHOA—asthma	3.12e-06	1.79e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—PDGFB—asthma	3.12e-06	1.79e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—EGFR—asthma	3.11e-06	1.78e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—EGFR—asthma	3.1e-06	1.78e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—NOS3—asthma	3.1e-06	1.78e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—NOS3—asthma	3.09e-06	1.77e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—SMAD3—asthma	3.09e-06	1.77e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—TGFB1—asthma	3.09e-06	1.77e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—EGFR—asthma	3.08e-06	1.76e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CCL2—asthma	3.06e-06	1.75e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL6R—asthma	3.05e-06	1.75e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—VEGFA—asthma	3.04e-06	1.74e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—EGFR—asthma	3.02e-06	1.73e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PLA2G4A—asthma	3.01e-06	1.73e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—GSTM1—asthma	3.01e-06	1.73e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—STAT3—asthma	3.01e-06	1.72e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—STAT3—asthma	3.01e-06	1.72e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—STAT3—asthma	3e-06	1.72e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—LEP—asthma	2.98e-06	1.71e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ALOX15—asthma	2.97e-06	1.7e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ALOX5AP—asthma	2.97e-06	1.7e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—POMC—asthma	2.97e-06	1.7e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—IL6—asthma	2.97e-06	1.7e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—NQO1—asthma	2.96e-06	1.7e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—SERPINE1—asthma	2.96e-06	1.7e-05	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—IL6—asthma	2.96e-06	1.7e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PPP2CA—asthma	2.96e-06	1.69e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CXCL8—asthma	2.95e-06	1.69e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—BCL2—asthma	2.95e-06	1.69e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL1B—asthma	2.94e-06	1.69e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—CD4—asthma	2.94e-06	1.69e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL2—asthma	2.93e-06	1.68e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—TGFB1—asthma	2.93e-06	1.68e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IFNG—asthma	2.92e-06	1.67e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—PTGS2—asthma	2.92e-06	1.67e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—TGFB1—asthma	2.92e-06	1.67e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CCR5—asthma	2.9e-06	1.66e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ADCY2—asthma	2.9e-06	1.66e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CXCL8—asthma	2.9e-06	1.66e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—asthma	2.88e-06	1.65e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—EGFR—asthma	2.87e-06	1.64e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—EGFR—asthma	2.86e-06	1.64e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL2RA—asthma	2.86e-06	1.64e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—SERPINE1—asthma	2.86e-06	1.64e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—RHOA—asthma	2.86e-06	1.64e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—GSTP1—asthma	2.84e-06	1.63e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—C3—asthma	2.84e-06	1.63e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CHAT—asthma	2.83e-06	1.62e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—NOS3—asthma	2.83e-06	1.62e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD4—asthma	2.82e-06	1.62e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—IL2—asthma	2.82e-06	1.62e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—FN1—asthma	2.81e-06	1.61e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—HMOX1—asthma	2.8e-06	1.6e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—NQO1—asthma	2.79e-06	1.6e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ITPR1—asthma	2.79e-06	1.6e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TGFB1—asthma	2.79e-06	1.6e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PPP2CA—asthma	2.77e-06	1.59e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—IL2—asthma	2.77e-06	1.59e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PDGFB—asthma	2.76e-06	1.58e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CAT—asthma	2.76e-06	1.58e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—PTEN—asthma	2.76e-06	1.58e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—RHOA—asthma	2.76e-06	1.58e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CXCL8—asthma	2.75e-06	1.58e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CXCL8—asthma	2.74e-06	1.57e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—EGFR—asthma	2.74e-06	1.57e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ADCY2—asthma	2.73e-06	1.57e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—EGFR—asthma	2.73e-06	1.57e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—NOS3—asthma	2.73e-06	1.56e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—EGFR—asthma	2.72e-06	1.56e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—ALB—asthma	2.71e-06	1.55e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—MMP9—asthma	2.67e-06	1.53e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—PTEN—asthma	2.65e-06	1.52e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—LEP—asthma	2.64e-06	1.51e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IL2—asthma	2.63e-06	1.51e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IL2—asthma	2.62e-06	1.5e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—MMP9—asthma	2.62e-06	1.5e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—IL6—asthma	2.62e-06	1.5e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—GSTM1—asthma	2.61e-06	1.49e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PLA2G4A—asthma	2.61e-06	1.49e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—PTEN—asthma	2.61e-06	1.49e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL1B—asthma	2.61e-06	1.49e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—CD4—asthma	2.6e-06	1.49e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL2—asthma	2.6e-06	1.49e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—NOS3—asthma	2.59e-06	1.48e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—PTGS2—asthma	2.59e-06	1.48e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—POMC—asthma	2.56e-06	1.47e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—IL6—asthma	2.56e-06	1.47e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—PTEN—asthma	2.55e-06	1.46e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ALOX5—asthma	2.53e-06	1.45e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—IL6—asthma	2.52e-06	1.44e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CCL2—asthma	2.51e-06	1.44e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL6R—asthma	2.5e-06	1.43e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—FN1—asthma	2.49e-06	1.43e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—MMP9—asthma	2.49e-06	1.43e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—MMP9—asthma	2.48e-06	1.42e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—PTEN—asthma	2.47e-06	1.42e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GSTP1—asthma	2.47e-06	1.42e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—STAT3—asthma	2.47e-06	1.41e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—PTEN—asthma	2.47e-06	1.41e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—PTEN—asthma	2.44e-06	1.4e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—HMOX1—asthma	2.44e-06	1.4e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ITPR1—asthma	2.43e-06	1.39e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CXCL8—asthma	2.42e-06	1.39e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—IL6—asthma	2.41e-06	1.38e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CARM1—asthma	2.41e-06	1.38e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CAT—asthma	2.41e-06	1.38e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PPP2CA—asthma	2.4e-06	1.38e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—VEGFA—asthma	2.4e-06	1.37e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IL6—asthma	2.39e-06	1.37e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IL6—asthma	2.38e-06	1.37e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—DCN—asthma	2.38e-06	1.36e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—STAT3—asthma	2.37e-06	1.36e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PTGS2—asthma	2.37e-06	1.36e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—IL6—asthma	2.37e-06	1.36e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—VEGFA—asthma	2.35e-06	1.35e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—SERPINE1—asthma	2.34e-06	1.34e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—STAT3—asthma	2.33e-06	1.34e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GSTP1—asthma	2.33e-06	1.34e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—IL6—asthma	2.32e-06	1.33e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL2—asthma	2.31e-06	1.32e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ALDH2—asthma	2.31e-06	1.32e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—HMOX1—asthma	2.3e-06	1.32e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ITPR1—asthma	2.29e-06	1.31e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—STAT3—asthma	2.28e-06	1.31e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PLA2G4A—asthma	2.27e-06	1.3e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GSTM1—asthma	2.27e-06	1.3e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—POMC—asthma	2.27e-06	1.3e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CAT—asthma	2.27e-06	1.3e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—RHOA—asthma	2.26e-06	1.29e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—PTEN—asthma	2.25e-06	1.29e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—EGFR—asthma	2.24e-06	1.28e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—NOS3—asthma	2.24e-06	1.28e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—VEGFA—asthma	2.23e-06	1.28e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—VEGFA—asthma	2.23e-06	1.28e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CCL2—asthma	2.22e-06	1.27e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL6R—asthma	2.21e-06	1.27e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—STAT3—asthma	2.21e-06	1.27e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—IL6—asthma	2.21e-06	1.26e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—STAT3—asthma	2.21e-06	1.26e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—IL6—asthma	2.2e-06	1.26e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TGFB1—asthma	2.2e-06	1.26e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GSTT1—asthma	2.2e-06	1.26e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MMP9—asthma	2.19e-06	1.25e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—STAT3—asthma	2.18e-06	1.25e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—PTEN—asthma	2.18e-06	1.25e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TGFB1—asthma	2.16e-06	1.24e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—EGFR—asthma	2.16e-06	1.24e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GSTM1—asthma	2.14e-06	1.23e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PLA2G4A—asthma	2.14e-06	1.23e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—POMC—asthma	2.13e-06	1.22e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—EGFR—asthma	2.12e-06	1.21e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—TGFB1—asthma	2.11e-06	1.21e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL6—asthma	2.1e-06	1.2e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—IL6—asthma	2.1e-06	1.2e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PPP2CA—asthma	2.09e-06	1.2e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL6—asthma	2.09e-06	1.2e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—SERPINE1—asthma	2.07e-06	1.19e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—EGFR—asthma	2.07e-06	1.19e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PTEN—asthma	2.07e-06	1.18e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TGFB1—asthma	2.05e-06	1.17e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TGFB1—asthma	2.05e-06	1.17e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—STAT3—asthma	2.02e-06	1.16e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—EGFR—asthma	2.01e-06	1.15e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—EGFR—asthma	2.01e-06	1.15e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—RHOA—asthma	2e-06	1.15e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—EGFR—asthma	1.99e-06	1.14e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CXCL8—asthma	1.98e-06	1.14e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—NOS3—asthma	1.98e-06	1.13e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PPP2CA—asthma	1.97e-06	1.13e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—VEGFA—asthma	1.97e-06	1.13e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—STAT3—asthma	1.95e-06	1.11e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—ALB—asthma	1.94e-06	1.11e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL2—asthma	1.9e-06	1.09e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—TGFB1—asthma	1.87e-06	1.07e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—NOS3—asthma	1.86e-06	1.06e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—POMC—asthma	1.84e-06	1.06e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—EGFR—asthma	1.83e-06	1.05e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—NQO1—asthma	1.83e-06	1.05e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TGFB1—asthma	1.8e-06	1.03e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MMP9—asthma	1.79e-06	1.03e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ADCY2—asthma	1.79e-06	1.02e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—PTEN—asthma	1.78e-06	1.02e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—EGFR—asthma	1.77e-06	1.01e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CXCL8—asthma	1.76e-06	1.01e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL6—asthma	1.72e-06	9.87e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PTGS2—asthma	1.7e-06	9.73e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ALB—asthma	1.68e-06	9.63e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL2—asthma	1.68e-06	9.61e-06	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—IL6—asthma	1.66e-06	9.5e-06	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—IL6—asthma	1.63e-06	9.33e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—VEGFA—asthma	1.61e-06	9.23e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—NOS3—asthma	1.61e-06	9.21e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—POMC—asthma	1.61e-06	9.2e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—STAT3—asthma	1.6e-06	9.14e-06	CbGpPWpGaD
Ponatinib—LCK—Disease—IL6—asthma	1.59e-06	9.12e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MMP9—asthma	1.59e-06	9.1e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PTEN—asthma	1.58e-06	9.05e-06	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IL6—asthma	1.55e-06	8.85e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IL6—asthma	1.54e-06	8.83e-06	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL6—asthma	1.53e-06	8.74e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GSTP1—asthma	1.52e-06	8.73e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—POMC—asthma	1.51e-06	8.67e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—HMOX1—asthma	1.5e-06	8.61e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ITPR1—asthma	1.5e-06	8.59e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CAT—asthma	1.48e-06	8.49e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PTEN—asthma	1.48e-06	8.48e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TGFB1—asthma	1.48e-06	8.47e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PTGS2—asthma	1.47e-06	8.42e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ALB—asthma	1.46e-06	8.39e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—EGFR—asthma	1.45e-06	8.31e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—VEGFA—asthma	1.43e-06	8.17e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—STAT3—asthma	1.41e-06	8.09e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—IL6—asthma	1.41e-06	8.07e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—NOS3—asthma	1.4e-06	8.02e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PLA2G4A—asthma	1.4e-06	8.02e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GSTM1—asthma	1.4e-06	8.02e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ALB—asthma	1.38e-06	7.91e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL6—asthma	1.36e-06	7.79e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—NOS3—asthma	1.32e-06	7.56e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TGFB1—asthma	1.31e-06	7.5e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PPP2CA—asthma	1.29e-06	7.39e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—EGFR—asthma	1.28e-06	7.35e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PTEN—asthma	1.28e-06	7.35e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PTGS2—asthma	1.28e-06	7.34e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PTGS2—asthma	1.21e-06	6.92e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PTEN—asthma	1.12e-06	6.4e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL6—asthma	1.11e-06	6.38e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PTEN—asthma	1.05e-06	6.03e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—POMC—asthma	9.89e-07	5.67e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL6—asthma	9.86e-07	5.65e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ALB—asthma	9.02e-07	5.17e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—NOS3—asthma	8.63e-07	4.94e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTGS2—asthma	7.89e-07	4.52e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTEN—asthma	6.88e-07	3.94e-06	CbGpPWpGaD
